Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Chromosomal instability accelerates the evolution of resistance to anti-cancer therapies

Developmental Cell(2021)10.1016/j.devcel.2021.07.009Source: DataRank Database

Chromosomal instability accelerates the evolution of resistance to anti-cancer therapies is a research paper published in Developmental Cell (2021). On theSindex it has a DataRank of 0. It has been cited 238 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access238 citations

Download PDF

Cite:

Linked data & code

bioproject cellosaurus

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (20 grants)Impact (FWCI 12.47)OA: greenTopics (37)Linked Datasets (4)DataCite Reuse (4)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (13)

Erin L. Sausville ORCID,Pavit Suri ORCID,Narendra Kumar Chunduri ORCID,Angela Wieland ORCID,Justin Leu ORCID

Live enrichment

PubMed:34352222 PMC:PMC8933054 OpenAlex:https://openalex.org/W3191628783

National Institutes of Health

Grant: 1DP5OD021385

National Institutes of Health

Grant: R01CA237652-01

U.S. Department of Defense

Grant: W81XWH-20-1-068

Simons Foundation

Grant: 519054

Deutsche Forschungsgemeinschaft

Grant: STO918-5

National Institute of Health and Medical Research

Grant: 5P30CA045508

Breast Cancer Research Foundation

Grant: 19-174

NCI NIH HHS

Grant: P30 CA045508

NCI NIH HHS

Grant: R01 CA237652

NIH HHS

Grant: DP5 OD021385

National Institutes of Health

Grant: 3P30CA045508-08S1

CSHL CANCER CENTER SUPPORT GRANT

National Institutes of Health

Grant: 5R01CA237652-06

Discovering the mechanisms of-action-mistargeted anti-cancer agents

Deutsche Forschungsgemeinschaft

Grant: unidentified

unidentified

National Institutes of Health

Grant: 5DP5OD021385-05

Identification and characterization of genomic features affecting survival duration in cancer

Damon Runyon Cancer Research Foundation

Tel Aviv University

American Cancer Society

Cold Spring Harbor Laboratory

New York Community Trust

Google

FWCI

12.47

Citation Percentile

1.0%

Citation Trend

2020

2021

2022

2023

2024

2025

2026

greenLicense: Elsevier Non-Commercial

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8933054

publisherhttps://api.elsevier.com/content/article/PII:S153458072100592X?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S153458072100592X?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.devcel.2021.07.009

Fields of Study

Cancer Genomics and DiagnosticsMicrotubule and mitosis dynamicsEvolution and Genetic Dynamics0301 basic medicine0303 health sciences03 medical and health sciences

MeSH Terms

AneuploidyDrug ResistanceEnvironmentHumansNeoplasmsTreatment OutcomeChromosomal InstabilityCell Line, Tumor

Keywords

AneuploidyBiologyChromosome instabilityCancerCancer cellPhenotypePaclitaxelCancer researchGenome instabilityChromosomeGeneticsGeneDNA damageDNAEvolutionDrug resistanceCINTreatment OutcomeCell Line, TumorChromosomal InstabilityNeoplasmsHumansEnvironment

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Additional file 1 of Exploiting DNA Ligase III addiction of multiple myeloma by flavonoid Rhamnetin

10.6084/m9.figshare.21384308.v1figshare

Additional file 1 of Exploiting DNA Ligase III addiction of multiple myeloma by flavonoid Rhamnetin

10.6084/m9.figshare.21384308figshare

Additional file 2 of Exploiting DNA Ligase III addiction of multiple myeloma by flavonoid Rhamnetin

10.6084/m9.figshare.21384311.v1figshare

Additional file 2 of Exploiting DNA Ligase III addiction of multiple myeloma by flavonoid Rhamnetin

10.6084/m9.figshare.21384311figshare